BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27106018)

  • 1. Progestins inhibit calcitriol-induced CYP24A1 and synergistically inhibit ovarian cancer cell viability: An opportunity for chemoprevention.
    Rodriguez GC; Turbov J; Rosales R; Yoo J; Hunn J; Zappia KJ; Lund K; Barry CP; Rodriguez IV; Pike JW; Conrads TP; Darcy KM; Maxwell GL; Hamilton CA; Syed V; Thaete LG
    Gynecol Oncol; 2016 Oct; 143(1):159-167. PubMed ID: 27106018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1.
    Bokhari AA; Lee LR; Raboteau D; Turbov J; Rodriguez IV; Pike JW; Hamilton CA; Maxwell GL; Rodriguez GC; Syed V
    Oncotarget; 2016 Nov; 7(47):77576-77590. PubMed ID: 27769055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells.
    Mukherjee K; Syed V; Ho SM
    Oncogene; 2005 Jun; 24(27):4388-400. PubMed ID: 15806153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestin-mediated activation of MAPK and AKT in nuclear progesterone receptor negative breast epithelial cells: The role of membrane progesterone receptors.
    Salazar M; Lerma-Ortiz A; Hooks GM; Ashley AK; Ashley RL
    Gene; 2016 Oct; 591(1):6-13. PubMed ID: 27349565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types.
    Paucarmayta A; Taitz H; Casablanca Y; Rodriguez GC; Maxwell GL; Darcy KM; Syed V
    Transl Cancer Res; 2019 Aug; 8(4):1423-1437. PubMed ID: 35116885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5α-dihydrotestosterone reduces renal
    Lee SR; Park MY; Yang H; Lee GS; An BS; Park BK; Jeung EB; Hong EJ
    J Mol Endocrinol; 2018 Feb; 60(2):159-170. PubMed ID: 29382742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D Analogs Regulate the Vitamin D System and Cell Viability in Ovarian Cancer Cells.
    Piatek K; Kutner A; Cacsire Castillo-Tong D; Manhardt T; Kupper N; Nowak U; Chodyński M; Marcinkowska E; Kallay E; Schepelmann M
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells.
    Miettinen S; Ahonen MH; Lou YR; Manninen T; Tuohimaa P; Syvälä H; Ylikomi T
    Int J Cancer; 2004 Jan; 108(3):367-73. PubMed ID: 14648702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of VDR and CYP24A1 mRNA in human tumors.
    Anderson MG; Nakane M; Ruan X; Kroeger PE; Wu-Wong JR
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):234-40. PubMed ID: 16180015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
    Kaufmann M; Lee SM; Pike JW; Jones G
    Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D, calcidiol and calcitriol regulate vitamin D metabolizing enzymes in cervical and ovarian cancer cells.
    Kloss M; Fischer D; Thill M; Friedrich M; Cordes T; Salehin D; Diedrich K; Köster F
    Anticancer Res; 2010 Nov; 30(11):4429-34. PubMed ID: 21115889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.
    Chow EC; Magomedova L; Quach HP; Patel R; Durk MR; Fan J; Maeng HJ; Irondi K; Anakk S; Moore DD; Cummins CL; Pang KS
    Gastroenterology; 2014 Apr; 146(4):1048-59. PubMed ID: 24365583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone induces apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression.
    Syed V; Mukherjee K; Godoy-Tundidor S; Ho SM
    J Cell Biochem; 2007 Oct; 102(2):442-52. PubMed ID: 17393432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenic Potential of CYP24A1 in Lung Adenocarcinoma.
    Shiratsuchi H; Wang Z; Chen G; Ray P; Lin J; Zhang Z; Zhao L; Beer D; Ray D; Ramnath N
    J Thorac Oncol; 2017 Feb; 12(2):269-280. PubMed ID: 27793774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone enhances calcitriol antitumor activity by upregulating vitamin D receptor expression and promoting apoptosis in endometrial cancer cells.
    Lee LR; Teng PN; Nguyen H; Hood BL; Kavandi L; Wang G; Turbov JM; Thaete LG; Hamilton CA; Maxwell GL; Rodriguez GC; Conrads TP; Syed V
    Cancer Prev Res (Phila); 2013 Jul; 6(7):731-43. PubMed ID: 23682076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells.
    Kósa JP; Horváth P; Wölfling J; Kovács D; Balla B; Mátyus P; Horváth E; Speer G; Takács I; Nagy Z; Horváth H; Lakatos P
    World J Gastroenterol; 2013 May; 19(17):2621-8. PubMed ID: 23674869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
    Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
    Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP24A1 inhibition enhances the antitumor activity of calcitriol.
    Muindi JR; Yu WD; Ma Y; Engler KL; Kong RX; Trump DL; Johnson CS
    Endocrinology; 2010 Sep; 151(9):4301-12. PubMed ID: 20591973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.